Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
about
Mechanisms of resistance to alkylating agentsBET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor ModelsEffect of non-steroidal anti-inflammatory drugs on colon carcinoma Caco-2 cell responsiveness to topoisomerase inhibitor drugsSynergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell linesTargeted knockdown of Bcl2 in tumor cells using a synthetic TRAIL 3'-UTR microRNAOptimization of circulating biomarkers of obatoclax-induced cell death in patients with small cell lung cancer.Bcl-2 and M-Myc coexpression increases IGF-IR and features of malignant growth in neuroblastoma cell linesBcl-2 inhibitor and apigenin worked synergistically in human malignant neuroblastoma cell lines and increased apoptosis with activation of extrinsic and intrinsic pathways.Bcl-2 inhibitor HA14-1 and genistein together adeptly down regulated survival factors and activated cysteine proteases for apoptosis in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cellsMolecular mechanisms of sulfasalazine-induced T-cell apoptosisPharmacologic management of high-risk neuroblastoma in childrenUp-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cellsTarantula cubensis extract alters the degree of apoptosis and mitosis in canine mammary adenocarcinomas.The relationship between cisplatin-induced apoptosis and p53, bcl-2 and bax expression in human lung cancer cells.Expression of apoptosis-regulatory genes in lung tumour cell lines: relationship to p53 expression and relevance to acquired drug resistanceMassive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by mutant c-H-ras oncogene expressionThe antisense bcl-2-IgH transcript is an optimal target for synthetic oligonucleotides.The Role of p53 in Marijuana Smoke Condensates-induced Genotoxicity and Apoptosis.Morphological and molecular assessment of apoptotic mechanisms in peripheral neuroblastic tumoursMolecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy.Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model.Dietary phytochemicals induce p53- and caspase-independent cell death in human neuroblastoma cells.New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence.Regulation of multidrug resistance by microRNAs in anti-cancer therapyApoptotic cell death in neuroblastoma.TRAIL combinations: The new 'trail' for cancer therapy (Review).The connections between neural crest development and neuroblastoma.Harnessing benefit from targeting tumor associated carbohydrate antigens.MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome.Potential molecular targets for Ewing's sarcoma therapy.Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity.Dexamethasone-resistant human Pre-B leukemia 697 cell line evolving elevation of intracellular glutathione level: an additional resistance mechanism.Bcl-X(L) antisense sensitizes human colon cancer cell line to 5-fluorouracil.Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types.Fas receptor is expressed in human lung squamous cell carcinomas, whereas bcl-2 and apoptosis are not pronounced: a preliminary report.Analysis of histological therapeutic effect, apoptosis rate and p53 status after combined treatment with radiation, hyperthermia and 5-fluorouracil suppositories for advanced rectal cancers.Differential sensitization of two human colon cancer cell lines to the antitumor effects of irinotecan combined with 5-aza-2'-deoxycytidine.Differential expression of DNA topoisomerase II alpha and II beta genes between small cell and non-small cell lung cancer.
P2860
Q24596948-92A7D1AE-7BEA-47FC-858D-2236414EF023Q27679878-E37C02C9-A0E1-48AE-878C-72CED21E7FBCQ28192910-9B039392-E8EC-4B20-86E1-09BDBBBA7C73Q28469349-A1FFC7D2-E951-4292-8ADB-0CDA3A6CE802Q34076762-2FAE406D-C488-4763-9E28-34795CD0E27DQ34763661-FA244C02-7D8D-4217-860C-6DF9E8310B00Q34780646-01E6F2DA-2AEC-4DB8-A3DE-BEBF123B29E7Q35013095-899FFD04-FE5B-46A5-83CF-DF6183CBE84DQ35013101-EF27B61F-0982-48E3-8853-8032F953F816Q35044669-051D6CCE-ECD5-462B-835C-1D8B7F27A939Q35064095-528B4188-4121-4E88-8255-413B78DB8540Q35788080-072561DD-2013-477A-AD3F-2A4644242A48Q35790275-0DA174C1-D359-4798-9876-858EC4557CA6Q35938280-A0A67214-5FF0-47C5-9798-4E564CD2436EQ36135196-231BC596-5776-401E-BC53-EE3F5F851C2CQ36236394-EF807251-A9B1-40C5-B6EC-67DA48C6E8ECQ36303128-5CE7CC35-9E02-418C-ABF5-8999A3AA5556Q36341747-96109333-373A-472C-85E5-04EB7DE444C1Q36611543-FA669FC1-DFF5-4863-8481-C6F7D646C04FQ36953849-27F0F6A9-61AB-4F9E-B3D5-92C1B423FBA6Q37023777-698336BA-BF56-477D-BEBD-C3B99797B6E5Q37086200-85B1D06F-B73B-42E9-8A21-E64CECEF88C5Q37283380-5F8BD219-A92F-4068-87C5-343A36467A0AQ37422646-751B54F3-4120-4285-8340-3C69B2983192Q37587311-A0645C79-3C38-4712-B2A5-36348DD6AF8DQ37679253-0ADE7CDE-552F-4CE7-8221-41D673B397FFQ37719944-B6550BD8-262A-4693-9530-71A6F2150551Q37836006-4DA031E3-FB68-461A-B69A-BF68C54495F7Q39032812-650AA896-0612-406C-BF73-F0F8CAA4528EQ39297570-54D5B849-83C2-4C11-AA08-4778B2D9F6A6Q39650171-9307A9EC-9A22-4687-9772-5FA1631BB91AQ39764720-E7524DDC-72F3-48F4-91BE-CAD27D8DF70FQ40728828-A754CA7D-3120-4450-843D-3027AE87C692Q40858027-255486B0-0116-4024-AF2F-9EBB5A9960A8Q41076577-970075B4-12EB-4970-AE86-0F89F5ACA571Q41845513-64E75509-CE3B-431F-92AB-4B3D7646B7F6Q41848429-462ED5A3-606B-4E80-8D28-E2243B2B1579Q52726488-14B4D0BD-F3C1-4BA8-AFBC-FB0D43CE5093Q55094275-8085A43A-2502-44C6-857A-2BF0118F1D12
P2860
Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
@en
type
label
Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
@en
prefLabel
Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
@en
P2093
P1433
P1476
Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma
@en
P2093
Merchant AK
P304
P407
P577
1994-06-01T00:00:00Z